Search company, investor...

Predict your next investment

Ascension Ventures company logo
Corporate Venture
ascensionventures.org

Investments

146

Portfolio Exits

38

Funds

2

About Ascension Ventures

Ascension Ventures, a wholly owned subsidiary of Ascension Health, is a strategic health venture fund specializing in venture and growth equity investments in healthcare information technology and services, and medical devices and diagnostics.

Headquarters Location

101 South Hanley Road Suite 200

St. Louis, Missouri, 63105,

United States

314-733-8100

Want to inform investors similar to Ascension Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Ascension Ventures News

Credit Kudos secures £2.2m in latest funding round

Sep 21, 2023

Challenger credit bureau Credit Kudos has raised £2.2m in its latest funding round, led by Ascension Ventures. The injection of funds will be used to support growth in the UK and accelerate expansion plans into Europe. Funds will also be directed to the development of Credit Kudos’ Open Banking app. Recommended Reports The platform offers lenders, brokers and financial institutions access to a scoring system based on consumer consented data. The aim is to enable lenders to make better credit decisions, while helping more individuals to access credit. Existing investors NFT Ventures and Entrepreneur First’s Next Stage Fund also joined the funding round, while new backers included Sarah Willingham, Charlie Songhurst, John McAndrew and Graham Lund. Freddy Kelly, chief executive of Credit Kudos, said: “This investment allows us to scale up our business to meet the demands of a post-Open Banking and PSD2 world. This funding will be used to expand our engineering and development team to continue to deliver first to market technology across our platform, as well as supporting expansion into wider Europe.” “Credit Kudos is a core solution to tackle the lack of fair and affordable access to credit for customers, with thin files or no credit history,” added Emma Steele, investment manager for Ascension Ventures. “We back Freddy’s ambition to change the way the risk profile of a potential borrower is assessed. “By doing that, Credit Kudos has the potential to 1) advance financial inclusion by improving approval rates for people previously excluded by the system 2) help prevent borrowers from being forced into higher priced products and 3) make it easy for lenders to check affordability. We are excited to back the team on this journey.” Last year, Credit Kudos partnered with P2P platform Lending Works to help the firm automate its borrowing application process. Credit Kudos is able to pull data from prospective borrowers’ bank accounts, which will then be used to automatically fill the forms and upload documents required Lending Works’ loan application process. Share this article

Ascension Ventures Investments

146 Investments

Ascension Ventures has made 146 investments. Their latest investment was in Instylla as part of their Series B - II on August 8, 2023.

CBI Logo

Ascension Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/10/2023

Series B - II

Instylla

$30.03M

No

2

5/31/2023

Series C

Strive Health

$166M

No

7

1/17/2023

Series A

HotelRunner

$6.5M

Yes

1

12/7/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

8/30/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/10/2023

5/31/2023

1/17/2023

12/7/2022

8/30/2022

Round

Series B - II

Series C

Series A

Series B

Series A

Company

Instylla

Strive Health

HotelRunner

Subscribe to see more

Subscribe to see more

Amount

$30.03M

$166M

$6.5M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

7

1

10

10

Ascension Ventures Portfolio Exits

38 Portfolio Exits

Ascension Ventures has 38 portfolio exits. Their latest portfolio exit was Intelligent Medical Objects on March 31, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/31/2022

Acq - Fin

$99M

2

11/24/2021

IPO

$99M

Public

2

11/8/2021

Acquired

$99M

5

8/6/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/21/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/31/2022

11/24/2021

11/8/2021

8/6/2021

5/21/2021

Exit

Acq - Fin

IPO

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

2

5

10

10

Ascension Ventures Acquisitions

1 Acquisition

Ascension Ventures acquired 1 company. Their latest acquisition was Compassus on October 01, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/1/2019

Other

$99M

$0.25M

Acq - Fin

3

Date

10/1/2019

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

$0.25M

Note

Acq - Fin

Sources

3

Ascension Ventures Fund History

2 Fund Histories

Ascension Ventures has 2 funds, including Collaborative Health Ventures V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

3/5/2021

Collaborative Health Ventures V

$285M

2

12/6/2016

CHV IV

$99M

10

Closing Date

3/5/2021

12/6/2016

Fund

Collaborative Health Ventures V

CHV IV

Fund Type

Status

Amount

$285M

$99M

Sources

2

10

Ascension Ventures Team

5 Team Members

Ascension Ventures has 5 team members, including current Chief Investment Officer, Senior Managing Director, Ryan L. Schuler.

Name

Work History

Title

Status

Ryan L. Schuler

Chief Investment Officer, Senior Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Ryan L. Schuler

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Chief Investment Officer, Senior Managing Director

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.